Atypical antipsychotic, the Glossary

Table of Contents

1. 164 relations: Adjuvant therapy, Agranulocytosis, Alpha-1 adrenergic receptor, Alpha-1A adrenergic receptor, Alpha-2 adrenergic receptor, Amenorrhea, Amisulpride, Angioedema, Anticholinergic, Antipsychotic, Anxiety, Anxiety disorder, Aplastic anemia, Aripiprazole, Asenapine, Australia, Autism, Bipolar disorder, Blonanserin, Blood sugar level, Boxed warning, Brexpiprazole, British National Formulary, Cardiac arrest, Cariprazine, Carpipramine, Chlorpromazine, Cholesterol, Clocapramine, Clozapine, Creatine kinase, Creatinine, CYP1A2, CYP2D6, CYP3A4, Dementia, Department of Health and Aged Care, Diabetes, Disability, Dopamine receptor D1, Dopamine receptor D2, Dopamine receptor D3, Dopamine receptor D4, Dopaminergic pathways, Dorsolateral prefrontal cortex, Downregulation and upregulation, DSM-5, Dysphagia, Enzyme inhibitor, Eosinophilia, ... Expand index (114 more) »

2. Atypical antipsychotics
3. Psychopharmacology
4. Treatment of psychosis

Adjuvant therapy

Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial therapy to maximize its effectiveness.

See Atypical antipsychotic and Adjuvant therapy

Agranulocytosis

Agranulocytosis, also known as agranulosis or granulopenia, is an acute condition involving a severe and dangerous lowered white blood cell count (leukopenia, most commonly of neutrophils) and thus causing neutropenia in the circulating blood.

See Atypical antipsychotic and Agranulocytosis

Alpha-1 adrenergic receptor

alpha-1 (α1) adrenergic receptors are G protein-coupled receptors (GPCRs) associated with the Gq heterotrimeric G protein.

See Atypical antipsychotic and Alpha-1 adrenergic receptor

Alpha-1A adrenergic receptor

The alpha-1A adrenergic receptor (α1A adrenoreceptor), also known as ADRA1A, formerly known also as the alpha-1C adrenergic receptor, is an alpha-1 adrenergic receptor, and also denotes the human gene encoding it.

See Atypical antipsychotic and Alpha-1A adrenergic receptor

Alpha-2 adrenergic receptor

The alpha-2 (α2) adrenergic receptor (or adrenoceptor) is a G protein-coupled receptor (GPCR) associated with the Gi heterotrimeric G-protein.

See Atypical antipsychotic and Alpha-2 adrenergic receptor

Amenorrhea

Amenorrhea or amenorrhoea is the absence of a menstrual period in a female who has reached reproductive age.

See Atypical antipsychotic and Amenorrhea

Amisulpride

Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; and at higher doses by mouth to treat schizophrenia and acute psychotic episodes. Atypical antipsychotic and Amisulpride are atypical antipsychotics.

See Atypical antipsychotic and Amisulpride

Angioedema

Angioedema is an area of swelling (edema) of the lower layer of skin and tissue just under the skin or mucous membranes.

See Atypical antipsychotic and Angioedema

Anticholinergic

Anticholinergics (anticholinergic agents) are substances that block the action of the acetylcholine (ACh) neurotransmitter at synapses in the central and peripheral nervous system.

See Atypical antipsychotic and Anticholinergic

Antipsychotic

Antipsychotics, previously known as neuroleptics and major tranquilizers, are a class of psychotropic medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders.

See Atypical antipsychotic and Antipsychotic

Anxiety

Anxiety is an emotion which is characterised by an unpleasant state of inner turmoil and includes feelings of dread over anticipated events.

See Atypical antipsychotic and Anxiety

Anxiety disorder

Anxiety disorders are a group of mental disorders characterized by significant and uncontrollable feelings of anxiety and fear such that a person's social, occupational, and personal functions are significantly impaired.

See Atypical antipsychotic and Anxiety disorder

Aplastic anemia

Aplastic anemia (AA) is a severe hematologic condition in which the body fails to make blood cells in sufficient numbers.

See Atypical antipsychotic and Aplastic anemia

Aripiprazole

Aripiprazole, sold under the brand names Abilify and Aristada, among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia and bipolar disorder; other uses include as an add-on treatment in major depressive disorder and obsessive compulsive disorder (OCD), tic disorders, and irritability associated with autism. Atypical antipsychotic and Aripiprazole are atypical antipsychotics.

See Atypical antipsychotic and Aripiprazole

Asenapine

Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder as well as the medium to long-term management of bipolar disorder. Atypical antipsychotic and Asenapine are atypical antipsychotics.

See Atypical antipsychotic and Asenapine

Australia

Australia, officially the Commonwealth of Australia, is a country comprising the mainland of the Australian continent, the island of Tasmania, and numerous smaller islands.

See Atypical antipsychotic and Australia

Autism

Autism, also called autism spectrum disorder (ASD) or autism spectrum condition (ASC), is a neurodevelopmental disorder characterised by symptoms of deficient reciprocal social communication and the presence of restricted, repetitive and inflexible patterns of behavior that are impairing in multiple contexts and excessive or atypical to be developmentally and socioculturally inappropriate.

See Atypical antipsychotic and Autism

Bipolar disorder

Bipolar disorder, previously known as manic depression, is a mental disorder characterized by periods of depression and periods of abnormally elevated mood that each last from days to weeks.

See Atypical antipsychotic and Bipolar disorder

Blonanserin

Blonanserin, sold under the brand name Lonasen, is a relatively new atypical antipsychotic (approved by PMDA in January 2008) commercialized by Dainippon Sumitomo Pharma in Japan and Korea for the treatment of schizophrenia. Atypical antipsychotic and Blonanserin are atypical antipsychotics.

See Atypical antipsychotic and Blonanserin

Blood sugar level

The blood sugar level, blood sugar concentration, blood glucose level, or glycemia is the measure of glucose concentrated in the blood.

See Atypical antipsychotic and Blood sugar level

Boxed warning

In the United States, a boxed warning (sometimes "black box warning", colloquially) is a type of warning that appears near the beginning of the package insert for certain prescription drugs, so called because the U.S. Food and Drug Administration specifies that it is formatted with a 'box' or border around the text to emphasize it is of utmost importance.

See Atypical antipsychotic and Boxed warning

Brexpiprazole

Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with dementia due to Alzheimer's disease. Atypical antipsychotic and Brexpiprazole are atypical antipsychotics.

See Atypical antipsychotic and Brexpiprazole

British National Formulary

The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS).

See Atypical antipsychotic and British National Formulary

Cardiac arrest

Cardiac arrest, also known as sudden cardiac arrest, is when the heart suddenly and unexpectedly stops beating.

See Atypical antipsychotic and Cardiac arrest

Cariprazine

Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, which is used in the treatment of schizophrenia, bipolar mania, bipolar depression, and major depressive disorder. Atypical antipsychotic and Cariprazine are atypical antipsychotics.

See Atypical antipsychotic and Cariprazine

Carpipramine

Carpipramine (Prazinil, Defekton) is an atypical antipsychotic used for the treatment of schizophrenia and anxiety in France and Japan. Atypical antipsychotic and Carpipramine are atypical antipsychotics.

See Atypical antipsychotic and Carpipramine

Chlorpromazine

Chlorpromazine (CPZ), marketed under the brand names Thorazine and Largactil among others, is an antipsychotic medication.

See Atypical antipsychotic and Chlorpromazine

Cholesterol

Cholesterol is the principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.

See Atypical antipsychotic and Cholesterol

Clocapramine

Clocapramine (Clofekton, Padrasen), also known as 3-chlorocarpipramine, is an atypical antipsychotic of the class which was introduced in Japan in 1974 by Yoshitomi for the treatment of schizophrenia. Atypical antipsychotic and Clocapramine are atypical antipsychotics.

See Atypical antipsychotic and Clocapramine

Clozapine

Clozapine is a psychiatric medication and was the first atypical antipsychotic (also called second-generation antipsychotic) to be discovered. Atypical antipsychotic and Clozapine are atypical antipsychotics.

See Atypical antipsychotic and Clozapine

Creatine kinase

Creatine kinase (CK), also known as creatine phosphokinase (CPK) or phosphocreatine kinase, is an enzyme expressed by various tissues and cell types.

See Atypical antipsychotic and Creatine kinase

Creatinine

Creatinine (from Ancient Greek: κρέας (kréas) 'flesh') is a breakdown product of creatine phosphate from muscle and protein metabolism.

See Atypical antipsychotic and Creatinine

CYP1A2

Cytochrome P450 1A2 (abbreviated CYP1A2), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism of xenobiotics in the human body.

See Atypical antipsychotic and CYP1A2

CYP2D6

Cytochrome P450 2D6 (CYP2D6) is an enzyme that in humans is encoded by the CYP2D6 gene.

See Atypical antipsychotic and CYP2D6

CYP3A4

Cytochrome P450 3A4 (abbreviated CYP3A4) is an important enzyme in the body, mainly found in the liver and in the intestine, which in humans is encoded by CYP3A4 gene.

See Atypical antipsychotic and CYP3A4

Dementia

Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities.

See Atypical antipsychotic and Dementia

Department of Health and Aged Care

The Department of Health and Aged Care (DHAC), formerly the Department of Health, is a department of the Australian Government responsible for health research, funding, promotion and regulation in Australia.

See Atypical antipsychotic and Department of Health and Aged Care

Diabetes

Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels.

See Atypical antipsychotic and Diabetes

Disability

Disability is the experience of any condition that makes it more difficult for a person to do certain activities or have equitable access within a given society.

See Atypical antipsychotic and Disability

Dopamine receptor D1

Dopamine receptor D1, also known as DRD1.

See Atypical antipsychotic and Dopamine receptor D1

Dopamine receptor D2

Dopamine receptor D2, also known as D2R, is a protein that, in humans, is encoded by the DRD2 gene. Atypical antipsychotic and Dopamine receptor D2 are Psychopharmacology.

See Atypical antipsychotic and Dopamine receptor D2

Dopamine receptor D3

Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.

See Atypical antipsychotic and Dopamine receptor D3

Dopamine receptor D4

The dopamine receptor D4 is a dopamine D2-like G protein-coupled receptor encoded by the gene on chromosome 11 at 11p15.5.

See Atypical antipsychotic and Dopamine receptor D4

Dopaminergic pathways

Dopaminergic pathways (dopamine pathways, dopaminergic projections) in the human brain are involved in both physiological and behavioral processes including movement, cognition, executive functions, reward, motivation, and neuroendocrine control.

See Atypical antipsychotic and Dopaminergic pathways

Dorsolateral prefrontal cortex

The dorsolateral prefrontal cortex (DLPFC or DL-PFC) is an area in the prefrontal cortex of the primate brain.

See Atypical antipsychotic and Dorsolateral prefrontal cortex

Downregulation and upregulation

In biochemistry, in the biological context of organisms' regulation of gene expression and production of gene products, downregulation is the process by which a cell decreases the production and quantities of its cellular components, such as RNA and proteins, in response to an external stimulus.

See Atypical antipsychotic and Downregulation and upregulation

DSM-5

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is the 2013 update to the Diagnostic and Statistical Manual of Mental Disorders, the taxonomic and diagnostic tool published by the American Psychiatric Association (APA).

See Atypical antipsychotic and DSM-5

Dysphagia

Dysphagia is difficulty in swallowing.

See Atypical antipsychotic and Dysphagia

Enzyme inhibitor

An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity.

See Atypical antipsychotic and Enzyme inhibitor

Eosinophilia

Eosinophilia is a condition in which the eosinophil count in the peripheral blood exceeds.

See Atypical antipsychotic and Eosinophilia

Erythema multiforme

Erythema multiforme (EM) is a skin condition that appears with red patches evolving into target lesions, typically on both hands.

See Atypical antipsychotic and Erythema multiforme

European Medicines Agency

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

See Atypical antipsychotic and European Medicines Agency

Exocytosis

Exocytosis is a form of active transport and bulk transport in which a cell transports molecules (e.g., neurotransmitters and proteins) out of the cell (exo- + cytosis).

See Atypical antipsychotic and Exocytosis

Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain's cerebral cortex.

See Atypical antipsychotic and Extrapyramidal symptoms

Food and Drug Administration

The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.

See Atypical antipsychotic and Food and Drug Administration

Galactorrhea

Galactorrhea (also spelled galactorrhoea) (galacto- + -rrhea) or lactorrhea (lacto- + -rrhea) is the spontaneous flow of milk from the breast, unassociated with childbirth or nursing.

See Atypical antipsychotic and Galactorrhea

Glaucoma

Glaucoma is a group of eye diseases that lead to damage of the optic nerve, which transmits visual information from the eye to the brain.

See Atypical antipsychotic and Glaucoma

GLP-1 receptor agonist

Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor.

See Atypical antipsychotic and GLP-1 receptor agonist

Gynecomastia

Gynecomastia (also spelled gynaecomastia) is the abnormal non-cancerous enlargement of one or both breasts in males due to the growth of breast tissue as a result of a hormone imbalance between estrogens and androgens.

See Atypical antipsychotic and Gynecomastia

Haloperidol

Haloperidol, sold under the brand name Haldol among others, is a typical antipsychotic medication.

See Atypical antipsychotic and Haloperidol

Health Products and Food Branch

The Health Products and Food Branch (HPFB) of Health Canada manages the health-related risks and benefits of health products and food by minimizing risk factors while maximizing the safety provided by the regulatory system and providing information to Canadians so they can make healthy, informed decisions about their health.

See Atypical antipsychotic and Health Products and Food Branch

Histamine H1 receptor

The H1 receptor is a histamine receptor belonging to the family of rhodopsin-like G-protein-coupled receptors.

See Atypical antipsychotic and Histamine H1 receptor

Hyperglycemia

Hyperglycemia or Hyperglycaemia is a condition in which an excessive amount of glucose circulates in the blood plasma.

See Atypical antipsychotic and Hyperglycemia

Hyperprolactinaemia

Hyperprolactinemia is characterized by abnormally high levels of prolactin in the blood.

See Atypical antipsychotic and Hyperprolactinaemia

Hypersensitivity

Hypersensitivity (also called hypersensitivity reaction or intolerance) is an abnormal physiological condition in which there is an undesirable and adverse immune response to an antigen.

See Atypical antipsychotic and Hypersensitivity

Hypotension

Hypotension, also known as low blood pressure, is a cardiovascular condition characterized by abnormally reduced blood pressure.

See Atypical antipsychotic and Hypotension

Iloperidone

Iloperidone, commonly known as Fanapt and previously known as Zomaril, is an atypical antipsychotic for the treatment of schizophrenia. Atypical antipsychotic and Iloperidone are atypical antipsychotics.

See Atypical antipsychotic and Iloperidone

Insulin resistance

Insulin resistance (IR) is a pathological condition in which cells either fail to respond normally to the hormone insulin or downregulate insulin receptors in response to hyperinsulinemia.

See Atypical antipsychotic and Insulin resistance

Intramuscular injection

Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle.

See Atypical antipsychotic and Intramuscular injection

Leukopenia

Leukopenia is a decrease in the number of leukocytes (WBC).

See Atypical antipsychotic and Leukopenia

List of antidepressants

This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

See Atypical antipsychotic and List of antidepressants

Lithium (medication)

Certain lithium compounds, also known as lithium salts, are used as psychiatric medication, primarily for bipolar disorder and for major depressive disorder.

See Atypical antipsychotic and Lithium (medication)

Lumateperone

Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. Atypical antipsychotic and Lumateperone are atypical antipsychotics.

See Atypical antipsychotic and Lumateperone

Lurasidone

Lurasidone, sold under the brand name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Atypical antipsychotic and Lurasidone are atypical antipsychotics.

See Atypical antipsychotic and Lurasidone

Major depressive disorder

Major depressive disorder (MDD), also known as clinical depression, is a mental disorder characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities.

See Atypical antipsychotic and Major depressive disorder

Mania

Mania, also known as manic syndrome, is a mental and behavioral disorder defined as a state of abnormally elevated arousal, affect, and energy level, or "a state of heightened overall activation with enhanced affective expression together with lability of affect." During a manic episode, an individual will experience rapidly changing emotions and moods, highly influenced by surrounding stimuli.

See Atypical antipsychotic and Mania

Medicines and Healthcare products Regulatory Agency

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

See Atypical antipsychotic and Medicines and Healthcare products Regulatory Agency

Melperone

Melperone (Bunil (PT), Buronil (AT, BE, CZ, DK, FL†, NL†, NO†, SE), Eunerpan (DE)) is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. Atypical antipsychotic and Melperone are atypical antipsychotics.

See Atypical antipsychotic and Melperone

Metabolic syndrome is a clustering of at least three of the following five medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL).

See Atypical antipsychotic and Metabolic syndrome

Metabolism (from μεταβολή metabolē, "change") is the set of life-sustaining chemical reactions in organisms.

See Atypical antipsychotic and Metabolism

Metformin

Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of typenbsp2 diabetes, particularly in people who are overweight.

See Atypical antipsychotic and Metformin

Mixed affective state

A mixed affective state, formerly known as a mixed-manic or mixed episode, has been defined as a state wherein features and symptoms unique to both depression and (hypo)mania, including episodes of anguish, despair, self doubt, rage, excessive impulsivity and suicidal ideation, sensory overload, racing thoughts, heightened irritability, decreased "need" for sleep and other symptoms of depressive and manic states occur either simultaneously or in very short succession.

See Atypical antipsychotic and Mixed affective state

Mosapramine

Mosapramine (Cremin) is an atypical antipsychotic used in Japan for the treatment of schizophrenia. Atypical antipsychotic and Mosapramine are atypical antipsychotics.

See Atypical antipsychotic and Mosapramine

Motor control

Motor control is the regulation of movements in organisms that possess a nervous system.

See Atypical antipsychotic and Motor control

Muscarinic acetylcholine receptor M1

The muscarinic acetylcholine receptor M1, also known as the cholinergic receptor, muscarinic 1, is a muscarinic receptor that in humans is encoded by the CHRM1 gene.

See Atypical antipsychotic and Muscarinic acetylcholine receptor M1

Muscarinic acetylcholine receptor M3

The muscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or the muscarinic 3, is a muscarinic acetylcholine receptor encoded by the human gene CHRM3.

See Atypical antipsychotic and Muscarinic acetylcholine receptor M3

Myocarditis

Myocarditis, also known as inflammatory cardiomyopathy, is an acquired cardiomyopathy due to inflammation of the heart muscle.

See Atypical antipsychotic and Myocarditis

National Health Service

The National Health Service (NHS) is the umbrella term for the publicly funded healthcare systems of the United Kingdom, comprising the NHS in England, NHS Scotland and NHS Wales.

See Atypical antipsychotic and National Health Service

National Institute of Mental Health

The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH).

See Atypical antipsychotic and National Institute of Mental Health

Neuroleptic malignant syndrome

Neuroleptic malignant syndrome (NMS) is a rare but life-threatening reaction that can occur in response to antipsychotic (neuroleptic) medications.

See Atypical antipsychotic and Neuroleptic malignant syndrome

Neutropenia

Neutropenia is an abnormally low concentration of neutrophils (a type of white blood cell) in the blood.

See Atypical antipsychotic and Neutropenia

Nizatidine

Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease.

See Atypical antipsychotic and Nizatidine

Obesity

Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it can potentially have negative effects on health.

See Atypical antipsychotic and Obesity

Obsessive–compulsive disorder

Obsessive–compulsive disorder (OCD) is a mental and behavioral disorder in which an individual has intrusive thoughts (an obsession) and feels the need to perform certain routines (compulsions) repeatedly to relieve the distress caused by the obsession, to the extent where it impairs general function.

See Atypical antipsychotic and Obsessive–compulsive disorder

Off-label use

Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

See Atypical antipsychotic and Off-label use

Olanzapine

Olanzapine, sold under the brand name Zyprexa among others, is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. Atypical antipsychotic and Olanzapine are atypical antipsychotics.

See Atypical antipsychotic and Olanzapine

Olanzapine/fluoxetine

Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing olanzapine (Zyprexa), an atypical antipsychotic, and fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI). Atypical antipsychotic and Olanzapine/fluoxetine are atypical antipsychotics.

See Atypical antipsychotic and Olanzapine/fluoxetine

Orthostatic hypotension

Orthostatic hypotension, also known as postural hypotension, is a medical condition wherein a person's blood pressure drops when standing up or sitting down.

See Atypical antipsychotic and Orthostatic hypotension

Paliperidone

Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. Atypical antipsychotic and Paliperidone are atypical antipsychotics.

See Atypical antipsychotic and Paliperidone

Pancreatitis

Pancreatitis is a condition characterized by inflammation of the pancreas.

See Atypical antipsychotic and Pancreatitis

Parkinson's disease

Parkinson's disease (PD), or simply Parkinson's, is a long-term neurodegenerative disease of mainly the central nervous system that affects both the motor and non-motor systems of the body.

See Atypical antipsychotic and Parkinson's disease

Perospirone

Perospirone (Lullan) is an atypical antipsychotic of the azapirone family. Atypical antipsychotic and Perospirone are atypical antipsychotics.

See Atypical antipsychotic and Perospirone

Perphenazine

Perphenazine is a typical antipsychotic drug.

See Atypical antipsychotic and Perphenazine

Persecutory delusion

A persecutory delusion is a type of delusional condition in which the affected person believes that harm is going to occur to oneself by a persecutor, despite a clear lack of evidence.

See Atypical antipsychotic and Persecutory delusion

Pharmaceuticals and Medical Devices Agency

The (PhMDA) is an Independent Administrative Institution responsible for ensuring the safety, efficacy and quality of pharmaceuticals and medical devices in Japan.

See Atypical antipsychotic and Pharmaceuticals and Medical Devices Agency

Physicians' Desk Reference

The Prescriber's Digital Reference (PDR) is a compilation of manufacturers' prescribing information (package insert) on prescription drugs, updated regularly and published by ConnectiveRx.

See Atypical antipsychotic and Physicians' Desk Reference

Pimavanserin

Pimavanserin, sold under the brand name Nuplazid, is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer's disease psychosis, schizophrenia, agitation, and major depressive disorder. Atypical antipsychotic and Pimavanserin are atypical antipsychotics.

See Atypical antipsychotic and Pimavanserin

Pneumonia severity index

The pneumonia severity index (PSI) or PORT Score is a clinical prediction rule that medical practitioners can use to calculate the probability of morbidity and mortality among patients with community acquired pneumonia.

See Atypical antipsychotic and Pneumonia severity index

Potency (pharmacology)

In pharmacology, potency or biological potency is a measure of a drug's biological activity expressed in terms of the dose required to produce a pharmacological effect of given intensity.

See Atypical antipsychotic and Potency (pharmacology)

Priapism

Priapism is a condition in which a penis remains erect for hours in the absence of stimulation or after stimulation has ended.

See Atypical antipsychotic and Priapism

Prolactin

Prolactin (PRL), also known as lactotropin and mammotropin, is a protein best known for its role in enabling mammals to produce milk.

See Atypical antipsychotic and Prolactin

Psychomotor agitation

Psychomotor agitation is a symptom in various disorders and health conditions.

See Atypical antipsychotic and Psychomotor agitation

Psychosis

Psychosis is a condition of the mind or psyche that results in difficulties determining what is real and what is not real.

See Atypical antipsychotic and Psychosis

QT interval

The QT interval is a measurement made on an electrocardiogram used to assess some of the electrical properties of the heart.

See Atypical antipsychotic and QT interval

Quetiapine

Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. Atypical antipsychotic and Quetiapine are atypical antipsychotics.

See Atypical antipsychotic and Quetiapine

Receptor (biochemistry)

In biochemistry and pharmacology, receptors are chemical structures, composed of protein, that receive and transduce signals that may be integrated into biological systems.

See Atypical antipsychotic and Receptor (biochemistry)

Remoxipride

Remoxipride (Roxiam) is an atypical antipsychotic (although according to some sources it is a typical antipsychotic) which was previously used in Europe for the treatment of schizophrenia and acute mania but was withdrawn due to toxicity concerns (incidence of aplastic anemia in 1/10,000 patients). Atypical antipsychotic and Remoxipride are atypical antipsychotics.

See Atypical antipsychotic and Remoxipride

Respiratory arrest

Respiratory arrest is a serious medical condition caused by apnea or respiratory dysfunction severe enough that it will not sustain the body (such as agonal breathing).

See Atypical antipsychotic and Respiratory arrest

Rhabdomyolysis

Rhabdomyolysis (shortened as rhabdo) is a condition in which damaged skeletal muscle breaks down rapidly, often due to high intensity exercise over a short period of time.

See Atypical antipsychotic and Rhabdomyolysis

Risperidone

Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Atypical antipsychotic and Risperidone are atypical antipsychotics.

See Atypical antipsychotic and Risperidone

Schizophrenia

Schizophrenia is a mental disorder characterized by reoccurring episodes of psychosis that are correlated with a general misperception of reality.

See Atypical antipsychotic and Schizophrenia

Sedative

A sedative or tranquilliser is a substance that induces sedation by reducing irritability or excitement.

See Atypical antipsychotic and Sedative

Seizure

A seizure is a period of symptoms due to abnormally excessive or synchronous neuronal activity in the brain.

See Atypical antipsychotic and Seizure

Serotonin

Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.

See Atypical antipsychotic and Serotonin

Sertindole

Sertindole, sold under the brand name Serdolect among others, is an antipsychotic medication. Atypical antipsychotic and Sertindole are atypical antipsychotics.

See Atypical antipsychotic and Sertindole

Sexual dysfunction

Sexual dysfunction is difficulty experienced by an individual or partners during any stage of normal sexual activity, including physical pleasure, desire, preference, arousal, or orgasm.

See Atypical antipsychotic and Sexual dysfunction

Signs and symptoms

Signs and symptoms are the observed or detectable signs, and experienced symptoms of an illness, injury, or condition.

See Atypical antipsychotic and Signs and symptoms

Skeletal formula

The skeletal formula, line-angle formula, bond-line formula or shorthand formula of an organic compound is a type of molecular structural formula that serves as a shorthand representation of a molecule's bonding and some details of its molecular geometry.

See Atypical antipsychotic and Skeletal formula

Spasticity

Spasticity is a feature of altered skeletal muscle performance with a combination of paralysis, increased tendon reflex activity, and hypertonia.

See Atypical antipsychotic and Spasticity

Status epilepticus

Status epilepticus (SE), or status seizure, is a medical condition consisting of a single seizure lasting more than 5 minutes, or 2 or more seizures within a 5-minute period without the person returning to normal between them.

See Atypical antipsychotic and Status epilepticus

Stevens–Johnson syndrome

Stevens–Johnson syndrome (SJS) is a type of severe skin reaction.

See Atypical antipsychotic and Stevens–Johnson syndrome

Stroke

Stroke (also known as a cerebrovascular accident (CVA) or brain attack) is a medical condition in which poor blood flow to the brain causes cell death.

See Atypical antipsychotic and Stroke

Suicidal ideation

Suicidal ideation, or suicidal thoughts, is the thought process of having ideas, or ruminations about the possibility of completing suicide.

See Atypical antipsychotic and Suicidal ideation

Sulpiride

Sulpiride, sold under the brand name Dogmatil among others, is an atypical antipsychotic (although some texts have referred to it as a typical antipsychotic) medication of the benzamide class which is used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and is sometimes used in low dosage to treat anxiety and mild depression. Atypical antipsychotic and Sulpiride are atypical antipsychotics.

See Atypical antipsychotic and Sulpiride

Syncope (medicine)

Syncope, commonly known as fainting or passing out, is a loss of consciousness and muscle strength characterized by a fast onset, short duration, and spontaneous recovery.

See Atypical antipsychotic and Syncope (medicine)

Tardive dyskinesia

Tardive dyskinesia (TD) is a disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips.

See Atypical antipsychotic and Tardive dyskinesia

The Lancet

The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind.

See Atypical antipsychotic and The Lancet

Therapeutic Goods Administration

The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government.

See Atypical antipsychotic and Therapeutic Goods Administration

Therapy

A therapy or medical treatment is the attempted remediation of a health problem, usually following a medical diagnosis.

See Atypical antipsychotic and Therapy

Thrombocytopenia

In hematology, thrombocytopenia is a condition characterized by abnormally low levels of platelets (also known as thrombocytes) in the blood.

See Atypical antipsychotic and Thrombocytopenia

Thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura (TTP) is a blood disorder that results in blood clots forming in small blood vessels throughout the body.

See Atypical antipsychotic and Thrombotic thrombocytopenic purpura

Thrombus

A thrombus (thrombi), colloquially called a blood clot, is the final product of the blood coagulation step in hemostasis.

See Atypical antipsychotic and Thrombus

Topiramate

Topiramate, sold under the brand name Topamax among others, is a medication used to treat epilepsy and prevent migraines.

See Atypical antipsychotic and Topiramate

Tremor

A tremor is an involuntary, somewhat rhythmic, muscle contraction and relaxation involving oscillations or twitching movements of one or more body parts.

See Atypical antipsychotic and Tremor

Triglyceride

A triglyceride (from tri- and glyceride; also TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids.

See Atypical antipsychotic and Triglyceride

Typical antipsychotic

Typical antipsychotics (also known as major tranquilizers, and first generation antipsychotics) are a class of antipsychotic drugs first developed in the 1950s and used to treat psychosis (in particular, schizophrenia). Atypical antipsychotic and Typical antipsychotic are treatment of psychosis.

See Atypical antipsychotic and Typical antipsychotic

UGT1A4

UDP-glucuronosyltransferase 1-4 is an enzyme that in humans is encoded by the UGT1A4 gene.

See Atypical antipsychotic and UGT1A4

United Kingdom

The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (UK) or Britain, is a country in Northwestern Europe, off the coast of the continental mainland.

See Atypical antipsychotic and United Kingdom

United States

The United States of America (USA or U.S.A.), commonly known as the United States (US or U.S.) or America, is a country primarily located in North America.

See Atypical antipsychotic and United States

United States National Library of Medicine

The United States National Library of Medicine (NLM), operated by the United States federal government, is the world's largest medical library.

See Atypical antipsychotic and United States National Library of Medicine

University of Manchester

The University of Manchester is a public research university in Manchester, England.

See Atypical antipsychotic and University of Manchester

Valproate

Valproate (valproic acid, VPA, sodium valproate, and valproate semisodium forms) are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches.

See Atypical antipsychotic and Valproate

The ventromedial prefrontal cortex (vmPFC) is a part of the prefrontal cortex in the mammalian brain.

See Atypical antipsychotic and Ventromedial prefrontal cortex

WebMD

WebMD is an American corporation which publishes online news and information about human health and well-being.

See Atypical antipsychotic and WebMD

Ziprasidone

Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Atypical antipsychotic and Ziprasidone are atypical antipsychotics.

See Atypical antipsychotic and Ziprasidone

Zonisamide

Zonisamide, sold under the brand name Zonegran among others, is a medication used to treat the symptoms of epilepsy and Parkinson's disease.

See Atypical antipsychotic and Zonisamide

Zotepine

Zotepine is an atypical antipsychotic drug indicated for acute and chronic schizophrenia. Atypical antipsychotic and Zotepine are atypical antipsychotics.

See Atypical antipsychotic and Zotepine

5-HT1A receptor

The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptors, or 5-HT receptors, that binds serotonin, also known as 5-HT, a neurotransmitter.

See Atypical antipsychotic and 5-HT1A receptor

5-HT1B receptor

5-hydroxytryptamine receptor 1B also known as the 5-HT1B receptor is a protein that in humans is encoded by the HTR1B gene.

See Atypical antipsychotic and 5-HT1B receptor

5-HT2A receptor

The 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR).

See Atypical antipsychotic and 5-HT2A receptor

5-HT2C receptor

The 5-HT2C receptor is a subtype of the 5-HT2 receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).

See Atypical antipsychotic and 5-HT2C receptor

5-HT3 receptor

The 5-HT3 receptor belongs to the Cys-loop superfamily of ligand-gated ion channels (LGICs) and therefore differs structurally and functionally from all other 5-HT receptors (5-hydroxytryptamine, or serotonin receptors) which are G protein-coupled receptors.

See Atypical antipsychotic and 5-HT3 receptor

5-HT6 receptor

The 5HT6 receptor is a subtype of 5HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5HT).

See Atypical antipsychotic and 5-HT6 receptor

5-HT7 receptor

The 5-HT7 receptor is a member of the GPCR superfamily of cell surface receptors and is activated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).

See Atypical antipsychotic and 5-HT7 receptor

See also

Atypical antipsychotics

• Amisulpride
• Amoxapine
• Aripiprazole
• Aripiprazole/sertraline
• Asenapine
• Atypical antipsychotic
• Bifeprunox
• Blonanserin
• Brexpiprazole
• Brilaroxazine
• Bromerguride
• Cariprazine
• Carpipramine
• Clocapramine
• Clotiapine
• Clozapine
• Cycloserine/lurasidone
• DHA-clozapine
• Gevotroline
• Iloperidone
• Lumateperone
• Lurasidone
• Melperone
• Mosapramine
• Nemonapride
• Olanzapine
• Olanzapine/fluoxetine
• Olanzapine/samidorphan
• Paliperidone
• Perospirone
• Pimavanserin
• Piquindone
• Quetiapine
• Remoxipride
• Risperidone
• Sertindole
• Sulpiride
• Sultopride
• Tenilapine
• Tiapride
• Zicronapine
• Ziprasidone
• Zotepine

Psychopharmacology

• Alcohol withdrawal syndrome
• Antidepressants
• Antipsychotics
• Atypical antipsychotic
• Dopamine receptor D2
• Drug resistance
• Ethnopsychopharmacology
• Insulin shock therapy
• Journal of Child and Adolescent Psychopharmacology
• List of psychiatric medications by condition treated
• Mood stabilizers
• Neuropsychopharmacology
• Pharmaco-electroencephalography
• Pharmacological dissection
• Psychiatric pharmacy
• Psychopharmacology
• Psychopharmacology revolution
• Release modulator
• Reuptake enhancer
• Reuptake modulator
• S-Adenosyl methionine
• Scandinavian College of Neuropsychopharmacology
• Stimulant
• Sulfozinum
• Truth serum

Treatment of psychosis

• Atypical antipsychotic
• Coordinated Specialty Care
• Early intervention in psychosis
• Open Dialogue
• Typical antipsychotic

References

[1] https://en.wikipedia.org/wiki/Atypical_antipsychotic

Also known as Adverse effects of atypical antipsychotics, Atypical antipsychotic agents, Atypical antipsychotics, Atypical medications (antipsychotics), Atypical neuroleptic, Second-generation antipsychotic, Second-generation antipsychotics, Serotonin-dopamine antagonist, Side effects of atypical antipsychotics.

, Erythema multiforme, European Medicines Agency, Exocytosis, Extrapyramidal symptoms, Food and Drug Administration, Galactorrhea, Glaucoma, GLP-1 receptor agonist, Gynecomastia, Haloperidol, Health Products and Food Branch, Histamine H1 receptor, Hyperglycemia, Hyperprolactinaemia, Hypersensitivity, Hypotension, Iloperidone, Insulin resistance, Intramuscular injection, Leukopenia, List of antidepressants, Lithium (medication), Lumateperone, Lurasidone, Major depressive disorder, Mania, Medicines and Healthcare products Regulatory Agency, Melperone, Metabolic syndrome, Metabolism, Metformin, Mixed affective state, Mosapramine, Motor control, Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M3, Myocarditis, National Health Service, National Institute of Mental Health, Neuroleptic malignant syndrome, Neutropenia, Nizatidine, Obesity, Obsessive–compulsive disorder, Off-label use, Olanzapine, Olanzapine/fluoxetine, Orthostatic hypotension, Paliperidone, Pancreatitis, Parkinson's disease, Perospirone, Perphenazine, Persecutory delusion, Pharmaceuticals and Medical Devices Agency, Physicians' Desk Reference, Pimavanserin, Pneumonia severity index, Potency (pharmacology), Priapism, Prolactin, Psychomotor agitation, Psychosis, QT interval, Quetiapine, Receptor (biochemistry), Remoxipride, Respiratory arrest, Rhabdomyolysis, Risperidone, Schizophrenia, Sedative, Seizure, Serotonin, Sertindole, Sexual dysfunction, Signs and symptoms, Skeletal formula, Spasticity, Status epilepticus, Stevens–Johnson syndrome, Stroke, Suicidal ideation, Sulpiride, Syncope (medicine), Tardive dyskinesia, The Lancet, Therapeutic Goods Administration, Therapy, Thrombocytopenia, Thrombotic thrombocytopenic purpura, Thrombus, Topiramate, Tremor, Triglyceride, Typical antipsychotic, UGT1A4, United Kingdom, United States, United States National Library of Medicine, University of Manchester, Valproate, Ventromedial prefrontal cortex, WebMD, Ziprasidone, Zonisamide, Zotepine, 5-HT1A receptor, 5-HT1B receptor, 5-HT2A receptor, 5-HT2C receptor, 5-HT3 receptor, 5-HT6 receptor, 5-HT7 receptor.